ADS Annual Meeting 2016 – Day 2

The final day of the conference began with an Early Career Investigator Breakfast where junior faculty had the opportunity to discuss research ideas and pathways with senior faculty.

The Keynote Address, “Delirium Superimposed on Dementia” was presented by Dr. Alessandro Morandi.

The plenary session was moderated by Wes Ely, MD, MPH and featured two talks on “The Electroencephalogram and Delirium”.

The morning breakout sessions included a roundtable discussion of proposed nomenclature for cognitive change associated with anesthesia and surgery led by Lisbeth Evered, BSc, Mbiostat, PhD and Esther Oh, MD. A debate of whether changes in consciousness should remain as an element in delirium diagnosis was moderated by Dr. Jose Maldonado with Dr. James Rudolph taking the pro position and Mark Oldham, MD arguing the con.

BC Childress, PharmD, MBA, BCACP moderated the “Multidisiciplinary Approach for Addressing Delirium in the Acutely Ill”.

A concurrent presentation was given on “Getting to know the National Institute of Aging: Opportunities for Support of Training and Research”, featuring representatives from the NIA.

The conference concluded with a series of breakout sessions. Christine Waszynski, DNP-C, RN, GNP-C moderated, “Program of Research Generated from Delirium Registry”, and “Intervention for ICU Follow-up” was moderated by James Jackson, PsyD. Nathan Brummel, MD, MSCI, moderated a series of lectures, including Functional Near-Infared Spectroscopy as a tool to detect Delirium; the identification of per-operative cognitive and psychological risk factors for delirium; the interplay between S100B and core Alzheimer’s biomarkers in Delirium; intraoperative cerebral oxygentation and ICU Delirium; perioperative monitoring of regional cerebral oxygen saturation and postoperative Delirium; as well as the association of Delirium duration with supratherapeutic psychotropic drug exposure.

Timothy Girard, MD, MSCI moderated the final session with talks on the strong negative impact of Delirium on the cognitive trajectories of nursing home residents; the effect of Delirium’s arousal subtypes on functional status and cognition; the reduction of Delirium by Dexmedetomidine vs. Propofol Sedation after Cardiac Surgery; pharmacological management of Delirium trial; an RCT of Oral Risperidone, Haloperidol, or Placebo for Delirium management in Palliative Care; and an RCT of Prolonged Release Melatonin for prevention of Delirium in patients with Cancer.